Cabaltica, Rex B. G., et al. "Anxiety Disorders and Comorbid Medical Illness." General Hospital Psychiatry 30 3 (2008): 208-225. Kessler, R., M. Keller, and H. Wittchen. "The Epidemiology of Generalized Anxiety Disorder." Psychiatric Clinics of North America 24 (2001): 19-39. O'Brien, R. F., K. Kifugi, and P. Summergrad. "Medical Conditions with Psychiatric Manifestations." Adolescent Medicine Clinics 17 1 (2006): 49-77. Shearer, S. L. "Recent Advances in the Understanding and Treatment of Anxiety Disorders." Primary Care: Clinics in Office Practice 34 3 (2007): 475-504. General Koukopoulos, A. "Agitated Depression as a Mixed State and the Problem of Melancholia." Psychiatric Clinics of North America 22 3 (1999): 547-564. Source: Medical Disability Advisor
Because of the link between the autonomic nervous system and the fight-or-flight response in anxiety, medications that block this response may be helpful. One example is the beta-blocker family of medications usually used for high blood pressure . Beta-blockers stop some of the effects of epinephrine (adrenaline) that also is involved in anxiety and fear responses. Beta-blockers such as propranolol ( Inderal ) are sometimes used to decrease episodic anxiety (for example, performance anxiety or test anxiety), and may also relieve some of the physical symptoms associated with a panic attack .
Interoceptive Exposure: Some individuals with Social Phobia are fearful not only of social situations, but also of the anxious physical sensations (such as blushing, shaking, sweating, etc.) that can accompany them. Interoceptive exposure practices deliberately bring about these sensations through such activities as wearing a warm sweater to induce sweating in social situations. Just as exposure to feared situations leads to reductions in situational fear, exposure to feared sensations will lead to a reduction in anxiety over experiencing these feelings in social situations.